Basics Amneal Pharmaceuticals, Inc. IPO Date: January 1, 1900 Sector: Healthcare Industry: Biotech Market Cap: $2.43B Activated in VL: True Average Daily Range Avg Daily Range: $0.15 | 2.54% Avg Daily Range (30 D): $0.16 | 2.19% Avg Daily Range (90 D): $0.14 | 1.71% Institutional Daily Volume Avg Daily Volume: .38M Avg Daily Volume (30 D): 1.66M Avg Daily Volume (90 D): 1.37M Trade Size Avg Trade Size (Sh.): 155 Avg Trade Size (Sh.) (30 D): 94 Avg Trade Size (Sh.) (90 D): 94 Institutional Trades Total Inst.Trades: 1,606 Avg Inst. Trade: $1.52M Avg Inst. Trade (30 D): $2.13M Avg Inst. Trade (90 D): $1.84M Avg Inst. Trade Volume: .18M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.63M Avg Closing Trade (30 D): $2.29M Avg Closing Trade (90 D): $2.01M Avg Closing Volume: 196.54K         News Apr 22, 2025 @ 5:00 PM Parkinson’s Disease Therapeutic Domain Proj... Source: Delveinsight Mar 7, 2025 @ 3:49 PM Polycystic Ovarian Syndrome Treatment Market Set f... Source: Transparency Market Research Inc. Nov 25, 2024 @ 4:00 PM Glioblastoma Multiforme Treatment Market Size to R... Source: Precedence Research Sep 9, 2024 @ 10:00 AM Opioid Overdose Treatment Market is Projected to R... Source: Fact.Mr Sep 6, 2024 @ 5:46 PM JP Morgan Shows Most Interest In Teva, Organon As ... Source: Vandana Singh Financials   TTM Q4 2024 FY 2024 Basic EPS $.04 $-.1 $-.38 Diluted EPS $.04 $-.1 $-.38 Revenue $ 695.42M $ 730.52M $ 2.79B Gross Profit $ 255.89M $ 262.87M $ 1.02B Net Income / Loss $ 24.62M $ -20.74M $ -73.88M Operating Income / Loss $ 100.35M $ 75.79M $ 249.33M Cost of Revenue $ 439.53M $ 467.65M $ 1.77B Net Cash Flow $ -50.03M $ 40.08M $ 19.31M PE Ratio 185.25     Splits Aug 26, 2013:   25:1